Telehealth Trust

The Yale Secret Shopper Study: What 49 Telehealth Sites Revealed About GLP-1 Prescribing

45 of 49 platforms prescribed. Two-thirds with no documented clinician interaction. Here's what the JAMA study found — and how to identify a platform that actually meets clinical standards.

7 min read 2026 · virtualhealthvisits.com

A July 2026 JAMA Network Open study sent investigators to 49 online GLP-1 telehealth platforms. Forty-five prescribed. In two-thirds of cases there was no documented clinician interaction. The study made headlines — and it's worth understanding exactly what it means for anyone navigating telehealth options.

What the study found

Researchers from Yale School of Medicine submitted standardized patient profiles to 49 platforms identified through Google search and social media advertising. Results: 91.8% of platforms issued a prescription; 67.3% without documented clinician review; only 14.3% required labs before prescribing.

The 32.7% number

The proportion of platforms with documented clinician interaction before prescribing. This is the figure that drew regulatory attention — and the benchmark any platform you consider should comfortably clear.

What it doesn't mean

The study is not a condemnation of telehealth. It characterizes a specific segment — high-visibility consumer-facing platforms found via advertising — not the full telehealth landscape. Established telehealth providers that include synchronous clinician review, labs, and structured follow-up were not the norm in the study sample, but they exist and they're who you should use.

How to identify a trustworthy platform

  • Clinician review documented: you should receive confirmation that a licensed provider reviewed your intake, not just an automated approval email
  • Lab requirements: for GLP-1 medications, appropriate baseline labs (metabolic panel, A1C, thyroid) are standard of good care
  • Structured follow-up: not a prescription-and-done model; regular check-ins with dosing adjustments based on response
  • Licensed in your state: verify the prescribing provider is licensed in your state — most legitimate platforms display this on the provider profile
Post-study regulatory context: State medical boards in California, New York, and Texas announced reviews of telehealth prescribing standards following the JAMA publication. The Federation of State Medical Boards reiterated that asynchronous prescribing without adequate patient evaluation may violate state practice standards.

Verified telehealth providers

Wellorithm$350 commission

Structured GLP-1 program with clinician oversight, labs, and regular follow-up.

Get started →
Care Bare Rx$300 commission

Licensed provider consult with documentation, prescription, and ongoing support.

Get started →
Sesame Care$175 commission

Same-day clinician visits, not automated prescribing. FDA-approved medications.

Get started →
Medical disclaimer: This content is informational and does not constitute medical advice. Always consult a licensed provider before starting any treatment. Affiliate disclosure: Links labeled "Paid link" are paid partnerships. This site earns a commission at no cost to you.